Sales 2024 * | 46.24B 49.77B 68.05B | Sales 2025 * | 49.92B 53.73B 73.47B | Capitalization | 114B 123B 168B |
---|---|---|---|---|---|
Net income 2024 * | 7.13B 7.67B 10.49B | Net income 2025 * | 8.66B 9.32B 12.74B | EV / Sales 2024 * | 2.61 x |
Net Debt 2024 * | 6.56B 7.06B 9.66B | Net Debt 2025 * | 1.95B 2.1B 2.87B | EV / Sales 2025 * | 2.32 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
13.2
x | Employees | - |
Yield 2024 * |
4.21% | Yield 2025 * |
4.46% | Free-Float | 87.12% |
Latest transcript on Sanofi SA
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 19-08-31 |
Madeleine Roach
COO | Chief Operating Officer | 40 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 14-04-30 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 20-05-21 |
Frédéric Oudéa
CHM | Chairman | 60 | 22-09-01 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |